4//SEC Filing
Zabrowksi Dan 4
Accession 0001209191-23-047456
CIK 0001814140other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 7:42 PM ET
Size
5.9 KB
Accession
0001209191-23-047456
Insider Transaction Report
Form 4
Apexigen, Inc.APGN
Zabrowski Dan
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2023-08-23−100,000→ 0 totalExercise: $2.65Exp: 2032-09-29→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in three equal annual installments beginning on July 29, 2023. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023, by and among the Issuer, Pyxis Oncology, Inc. ("Pyxis"), and Ascent Merger Sub Corp., at the effective time of the merger (the "Effective Time"), the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time.
Documents
Issuer
Apexigen, Inc.
CIK 0001814140
Entity typeother
Related Parties
1- filerCIK 0001940818
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 7:42 PM ET
- Size
- 5.9 KB